Biotechnology, Medical, Pharmaceutical
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Series A · $33.6M · 97d agoalchemab.com
Hiring velocity
- Open roles
- 1
- Added, 30 days
- +1
- Added, 7 days
- +1
- Closed, 30 days
- 0
- Raised
- 97 days ago
- Led by
- RA Capital Management, British Business Bank, Eli Lilly, SV Health Investors, DCVC Bio
- Team size
- 51-100
- HQ
- London, England, United Kingdom
- Newest role
- 18h ago
- Tracked since
- Oct 14, 2026
Where they're hiring
Sales & BD1
Open roles at Alchemab Therapeutics
Source: alchemab.com, checked daily.